Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow Transplantation

New England Journal of Medicine

Volumn 314, Issue 16, 1986, Pages 1006-1010

  Bowden, Raleigh A ^a   Sayers, Merlin ^a   Flournoy, Nancy ^a   Newton, Barbara ^a   Banaji, Meera ^a   Thomas, E Donnall ^a   Meyers, Joel D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBULIN; IMMUNOGLOBULIN; VIRUS ANTIBODY;

BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOSUPPRESSIVE TREATMENT; PASSIVE IMMUNIZATION; PREVENTION; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0022575268     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198604173141602     Document Type: Article

References (18)

1. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478–88.
2. Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift R. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 1982; 96: 149–52.
3. Adler SP, Lawrence LT, Baggett J, Biro V, Sharp DE. Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus. Transfusion 1984; 24: 333–5.
4. Tolkoff-Rubin NE, Rubin RH, Keller EE, Baker GP, Stewart JA, Hirsch MS. Cytomegalovirus infection in dialysis patients and personnel. Ann Intern Med 1978; 89: 625–8.
5. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 1981; 98: 281–7.
6. Preiksaitis JK, Rosno S, Grumet C, Merigan TC. Infections due to herpesviruses in cardiac transplant recipients: role of the donor heart and immunosuppressive therapy. J Infect Dis 1983; 147: 974–81.
7. Plotkin SA, Smiley ML, Friedman HM, et al. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet 1984; 1: 528–30.
8. Winston DJ, Pollard RB, Ho WG, et al. Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intem Med 1982; 97: 11–8.
9. Meyers JD, Leszczynski J, Zaia JA, et al. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 1983; 98: 442–6.
10. Condie RM, O'Reilly RJ. Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin: randomized trial in bone marrow transplant recipients. Am J Med 1984; 76(3A):134–41.
11. Winston DJ, Ho WG, Lin CH, Budinger MD, Champlin RE, Gale RP. Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation: preliminary results of a controlled trial. Am J Med 1984; 76(3A):128–33.
12. Wentworth BB, Alexander ER. Seroepidemiology of infections due to members of the herpesvirus group. Am J Epidemiol 1971; 94: 496–507.
13. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959; 22: 719–48.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
15. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187–220.
16. Einhorn L, Öst Å. Cytomegalovirus infection of human blood cells. J Infect Dis 1984; 149: 207–14.
17. Schrier RD, Nelson JA, Oldstone MBA. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 1985; 230: 1048–51.
18. Diosi P, Moldovan E, Tomescu N. Latent cytomegalovirus infection in blood donors. Br Med J 1969; 4: 660–2.